Maximus (NYSE:MMS) Insider Michelle Link Sells 3,208 Shares of Stock

Maximus, Inc. (NYSE:MMS) insider Michelle Link sold 3,208 shares of the stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $54.23, for a total value of $173,969.84. Following the transaction, the insider owned 13,881 shares in the company, valued at $752,766.63. The trade was a 18.77% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Maximus Stock Performance

Shares of Maximus stock traded down $0.81 during trading on Friday, reaching $52.72. The company’s stock had a trading volume of 609,756 shares, compared to its average volume of 710,019. The business’s 50-day moving average price is $57.45 and its 200-day moving average price is $60.34. The firm has a market cap of $2.76 billion, a PE ratio of 7.79 and a beta of 0.59. Maximus, Inc. has a 52 week low of $51.04 and a 52 week high of $100.00. The company has a quick ratio of 2.42, a current ratio of 2.42 and a debt-to-equity ratio of 0.90.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, August 6th. The health services provider reported $2.22 EPS for the quarter, topping analysts’ consensus estimates of $2.21 by $0.01. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The business had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same period last year, the firm earned $2.16 earnings per share. Maximus’s revenue for the quarter was down 5.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Equities analysts forecast that Maximus, Inc. will post 8.03 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were issued a dividend of $0.33 per share. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.32 annualized dividend and a dividend yield of 2.5%. Maximus’s dividend payout ratio (DPR) is currently 19.50%.

Institutional Trading of Maximus

A number of institutional investors and hedge funds have recently made changes to their positions in the company. BlackRock Inc. acquired a new stake in shares of Maximus during the 2nd quarter worth approximately $400,186,000. Dimensional Fund Advisors LP raised its position in Maximus by 7.2% during the first quarter. Dimensional Fund Advisors LP now owns 2,107,278 shares of the health services provider’s stock valued at $135,084,000 after purchasing an additional 141,362 shares in the last quarter. Geode Capital Management LLC lifted its stake in Maximus by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 1,482,079 shares of the health services provider’s stock worth $127,952,000 after purchasing an additional 5,130 shares during the last quarter. Reinhart Partners LLC. lifted its stake in Maximus by 131.8% during the second quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider’s stock worth $106,575,000 after purchasing an additional 1,127,346 shares during the last quarter. Finally, Van Berkom & Associates Inc. boosted its holdings in shares of Maximus by 3.7% in the 1st quarter. Van Berkom & Associates Inc. now owns 1,172,190 shares of the health services provider’s stock valued at $75,137,000 after purchasing an additional 41,862 shares in the last quarter. Institutional investors own 97.21% of the company’s stock.

Analysts Set New Price Targets

MMS has been the topic of a number of analyst reports. Weiss Ratings reissued a “hold (c-)” rating on shares of Maximus in a research report on Monday, August 17th. Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Finally, Zacks Research downgraded Maximus from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 11th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Reduce”.

About Maximus

Maximus, Inc (NYSE:MMS) is a provider of government services and technology-enabled solutions. The company partners with federal, state, provincial and local governments to administer public programs, improve service delivery and support interactions between governments and the people they serve.

Its business activities include health and human services administration, employment and workforce services, child support and eligibility services, customer contact centers, program management, consulting and digital transformation.